In addition, SMARCA4/2 deletion reduces the expression of the Ca2+ channel IP3R3, which impairs the transfer of Ca2+ from the endoplasmic reticulum to the mitochondria required to induce apoptosis, leading to cisplatin resistance in ovarian and lung cancer (74). Here, SMARCA4 is linked to lung carcinoma.